Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
Recruiting · NCT06489548 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-02-12 | NCT06489548 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brigham and Women's Hospital | 378 |
| Tiziana Life Sciences LTD | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center for Alzheimer Research and Treatment, Brigham and Women's Hospital | Boston | United States | 1 |